MAPK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.851430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.169800E-01
Normal-vs-Stage2
1.969820E-01
Normal-vs-Stage3
4.849700E-02
Normal-vs-Stage4
5.754000E-01
Stage1-vs-Stage2
9.670400E-01
Stage1-vs-Stage3
2.028000E-01
Stage1-vs-Stage4
4.479000E-01
Stage2-vs-Stage3
1.704160E-01
Stage2-vs-Stage4
4.388200E-01
Stage3-vs-Stage4
7.968100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.611170E-01
Normal-vs-AfricanAmerican
9.354400E-01
Normal-vs-Asian
1.024830E-01
Caucasian-vs-AfricanAmerican
7.889900E-02
Caucasian-vs-Asian
2.392000E-01
AfricanAmerican-vs-Asian
8.119900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.716770E-01
Normal-vs-Female
2.191000E-01
Male-vs-Female
3.205200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.069580E-01
Normal-vs-Age(41-60Yrs)
3.978400E-01
Normal-vs-Age(61-80Yrs)
1.543590E-01
Normal-vs-Age(81-100Yrs)
2.037600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.699180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.430600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.413800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.792370E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.994010E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.579600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.804000E-02
Normal-vs-Daily Drinker
2.055800E-02
Normal-vs-Weekly Drinker
1.849390E-01
Normal-vs-Occasional Drinker
4.698000E-01
Normal-vs-Social Drinker
4.563200E-01
Non Drinker-vs-Daily Drinker
1.743590E-01
Non Drinker-vs-Weekly Drinker
5.322400E-01
Non Drinker-vs-Occasional Drinker
8.843800E-02
Non Drinker-vs-Social Drinker
2.509200E-01
Daily Drinker-vs-Weekly Drinker
9.056400E-02
Daily Drinker-vs-Occasional Drinker
8.704100E-03
Daily Drinker-vs-Social Drinker
4.672400E-02
Weekly Drinker-vs-Occasional Drinker
3.805000E-01
Weekly Drinker-vs-Social Drinker
6.341400E-01
Occasional Drinker-vs-Social Drinker
7.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.412000E-01
Normal-vs-Grade 2
7.551200E-01
Normal-vs-Grade 3
7.606000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.472800E-01
Grade 1-vs-Grade 3
7.171000E-01
Grade 1-vs-Grade 4
5.412000E-01
Grade 2-vs-Grade 3
9.160400E-01
Grade 2-vs-Grade 4
7.551200E-01
Grade 3-vs-Grade 4
7.606000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.527820E-01
Normal-vs-NonDiabetic
1.293380E-01
Diabetic-vs-NonDiabetic
7.066800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.332300E-02
Normal-vs-NoPancreatitis
1.473010E-01
Pancreatitis-vs-NoPancreatitis
8.835200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.942820E-01
Normal-vs-N1
2.023000E-01
N0-vs-N1
4.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.994400E-01
Normal-vs-TP53-NonMutant
2.850000E-01
TP53-Mutant-vs-TP53-NonMutant
4.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
